CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 

Cumulative Amgen Inc 's Quick Ratio for Trailing Twelve Months Period

AMGN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

AMGN Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth -3.44 % -13.49 % 0.13 % 4.56 % 49.12 %
Y / Y Cash & cash equivalent Growth -11.17 % -11.12 % -38.07 % -24.51 % 4.54 %
Quick Ratio for Trailing Twelve Months Period 0.64 0.66 0.65 0.73 0.78
Total Ranking # 2032 # 2712 # 2855 # 2892 # 2153
Seq. Current Liabilities Growth 13.58 % -2.08 % 5.76 % -17.91 % 1.76 %
Seq. Cash & cash equivalent Growth 59.79 % 9.76 % -18.58 % -37.8 % 59.87 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite year on year decrease in Amgen Inc 's average Current Liabilities to $14,331 millions, Quick Ratio for Trailing Twelve Months Period to 0.64 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 212 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Amgen Inc . While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 2032, from total ranking in previous quarter at 2712.

What is Quick Ratio?
Learn more about AMGN
Quick Ratio AMGN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 213
Sector # 822
S&P 500 # 2031


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
4.52 2.33 0.64
(Dec 31 2017)   (Sep 30 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Erytech Pharma S.a.  1.68 
Edwards Lifesciences Corporation  1.68 
Volitionrx Limited  1.64 
Xtant Medical Holdings Inc   1.63 
Agenus Inc  1.60 
Bio techne Corp  1.60 
Myriad Genetics Inc   1.60 
Lucira Health Inc   1.58 
Repligen Corp  1.58 
Meiragtx Holdings Plc  1.56 
Molecular Partners Ag  1.53 
Greenlight Biosciences Holdings Pbc  1.38 
Eiger Biopharmaceuticals Inc   1.37 
Senstar Technologies Ltd   1.37 
Champions Oncology Inc.  1.36 
Aerie Pharmaceuticals Inc   1.34 
Applied Uv Inc   1.33 
Cidara Therapeutics Inc   1.32 
Meridian Bioscience Inc   1.31 
Adma Biologics Inc   1.31 
Innate Pharma Sa  1.30 
Quidelortho Corp  1.21 
Qiagen N v   1.12 
Moderna Inc   1.10 
Fate Therapeutics Inc   1.09 
Eargo Inc   1.07 
Sab Biotherapeutics Inc   1.01 
Lantheus Holdings Inc   0.99 
U s Lighting Group Inc   0.97 
Bruker Corporation  0.95 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TUYA's Profile

Stock Price

TUYA's Financials

Business Description

Fundamentals

Charts & Quotes

TUYA's News

Suppliers

TUYA's Competitors

Customers & Markets

Economic Indicators

TUYA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071